AFFECT-EU

This project receives funding from the @EU_H2020 Research & Innovation Programme. Any related tweets reflect only the views of the project owner.

[AFFECT-EU @h2020affecteu]

💓AFFECT-EU's Final Conference on March 18 in Brussels & online was a hit! Key insights on Atrial Fibrillation prevention & screening, including risk calculators & wearables, were shared. Thanks to all the experts advancing AF care! 🚀
Read more about it on our website.
#AFFECTEU

[AFFECT-EU @h2020affecteu]

New findings from AFFECT-EU project suggest a 5-minute test during GP appointments could prevent strokes in high-risk individuals. Atrial fibrillation screening is crucial for early intervention.
#HeartHealth #StrokePrevention

Read more in https://t.co/ZPpk3xNkCB

[AFFECT-EU @h2020affecteu]

This is a reminder that registrations for our Final Event are open ! It will take place on March 18th 2024, in #Brussels. Don't miss out on the chance to learn more about Atrial Fibrillation screening and its benefits https://t.co/TPSbQPhjpE… #AFib
@EU_HaDEA

[AFFECT-EU @h2020affecteu]

We are pleased to announce our Final Event on March 18th 2024, in #Brussels! Registration is open on a first-come, first-served basis. Don't miss out on the chance to learn more about Atrial Fibrillation screening and its benefits https://t.co/TPSbQPhjpE
#AFib #CardioTwitter

[Lucas Xing @lucas_yxing]

Just released in @JAHA_AHA 📢

In this secondary analysis of #LOOPstudy we found that ABC-stroke score was:
❗️associated w/ cardioembolic #stroke but not other ischemic stroke subtypes 🧠
❗️not able to predict effects of #AFib 🫀screening

@RigsHeart @SZDiederichsen #EPeeps

[AFFECT-EU @h2020affecteu]

Learn more about the AFFECT-EU project and achievements in our latest video ! 👇

https://t.co/c47N8cdO1u

#CardioTwitter #AFib #AtrialFibrilation #Screening

[European Society of Cardiology @escardio]

#ESCTVToday - new episode 📺

Prof. Paulus Kirchof discusses the management of device-detected #Afib & the results of the NOAH-AFNET 6 & #ARTESIA trials https://t.co/qurgA1G7LB 👇

Sign up for episode reminders so you never miss a beat https://t.co/kXj70s9OC9

#CVD #cardioX #medX

[AFFECT-EU @h2020affecteu]

🔬 Exciting news for #AFib research! 🫀 Discover the ETNA-AF-Europe subanalysis results comparing 2-year outcomes in edoxaban-treated patients with AF based on cardiac status & LVEF.

📚 Read the full article here: https://t.co/vQDrBzg0Ie

#Cardiology #Research #Healthcare

[Dominik Linz @Dominik_Linz]

Was a pleasure to interview Renate Schnabel on:

📺 #ESCTV
👉🏻“#AFib screening in the digital era“

Please also consider joining us Monday, 10.15am, Hub Mondrian:

🎙️ #ESCCongress
👉🏻“Screening for #AFib: lessons learned“

@escardio @h2020affecteu

[AFFECT-EU @h2020affecteu]

On behalf of AF-SCREEN we are inviting you to take a quick survey on post-op AF, to help shaping global practice for better long-term management. Share your expert insights in less than 5 minutes: https://t.co/1C2lNZwOwI #AFSCREEN #ResearchOpportunity

[AFFECT-EU @h2020affecteu]

Is there a link between gut microbiome composition and #AtrialFibrilation ?

Find out the answer in this newly released publication: https://t.co/8hF37oul1E

#CardioTwitter #guthealth

[AFFECT-EU @h2020affecteu]

Just presented the latest developments of AFFECT-EU project at #EHRA2023 ! We were delighted to see so much attendance and interest in improving #AFib understanding and management.

#EHRA_ESC #CardioTwitter

[AFFECT-EU @h2020affecteu]

Do not miss the AFFECT-EU presentation part of "How to improve AF understanding and management? Focus on STEER-AF, AFFECT-EU & AFNET" at #EHRA2023 Congress in Barcelona today ! (13:15 - 14:15, Room 3)

For more information on session ➡️https://t.co/tfcfuojFQ0

[AFFECT-EU @h2020affecteu]

Excited to announce that AFFECT-EU will be participating in the EHRA Congress 2023!

Looking forward to sharing our latest research on atrial fibrillation and stroke prevention in Europe.

#EHRA2023 #AFFECTEU #atrialfibrillation #strokeprevention

[AFFECT-EU @h2020affecteu]

Excited to announce that AFFECT-EU will be participating in the EHRA Congress 2023!

Looking forward to sharing our latest research on atrial fibrillation and stroke prevention in Europe.

#EHRA2023 #AFFECTEU #atrialfibrillation #strokeprevention

[AFFECT-EU @h2020affecteu]

Don't miss the AFFECT-EU webinar on #rhythm monitoring: new #technologies, new strategies.
This is a joint webinar AFFECT-EU and EHRA.
Register now on https://t.co/PyPydOSLkZ

[AFFECT-EU @h2020affecteu]

Don't miss the #ESCSpringSummit2023, where you can explore the most recent trends and innovations influencing the future of cardiovascular health. Engage in a lively program of speakers, workshops, and networking events! #cardiovasculardisease #innovation #networking

[AFFECT-EU @h2020affecteu]

#AFFECTEU team wishes everyone a happy holiday season!
Keep up to date with our December newsletter: https://t.co/KrNVg6asNt

#CardioTwitter #AFSCREEN

[AFFECT-EU @h2020affecteu]

Discover the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) in our latest article published on EP Europace !

Access the article in open access here:
https://t.co/EX0QA4Qy5G

[AFFECT-EU @h2020affecteu]

Discover our latest study, published by @BMJ_Open which explores the perspectives of European stakeholders about the advantages and disadvantages of putting four AF screening scenarios into practice.

Read more: https://t.co/tGsU5I9NrM

[AFFECT-EU @h2020affecteu]

Don't miss Prof Giuseppe Boriani's presentation on Screening for rhythm disorders today at 10:10 ! It will be part of a broader discussion by experts on stroke and heart failure at the HFA 2022 congress (@HFA_President)

Link to the session below:
https://t.co/BUkmDmcH3R